Immune Markers May Flag Which Psoriasis Patients Respond Best to Ustekinumab
A retrospective study of 42 Chinese patients links the HLA-C*06:02 allele and elevated baseline IgE to faster and deeper skin ...
A retrospective study of 42 Chinese patients links the HLA-C*06:02 allele and elevated baseline IgE to faster and deeper skin ...
A multinational retrospective study of 801 severe asthma patients built a Random Forest model that doubled specificity in identifying likely ...
A prospective cohort study in Kyrgyzstan found that medication adherence, urban residence, smoking, and depressive symptoms were independently associated with ...
A narrative review synthesizes trial and real-world evidence suggesting ustekinumab can drive fistula healing in Crohn's disease, especially when combined ...
Vunakizumab, a new anti-IL-17A monoclonal antibody, is approved in China for adults with moderate-to-severe chronic plaque psoriasis after phase 3 ...
A prospective 12-month cohort study of 36 Saudi patients with lupus found that belimumab add-on therapy was associated with significant ...
A post hoc analysis of week 16 responders from the ADvocate trials found that most maintained deep skin and itch ...
The IL-23 blocker guselkumab significantly reduced disease severity compared with placebo in children and adolescents with moderate-to-severe plaque psoriasis in ...
A small prospective biopsy study suggests high-grade synovitis may identify difficult-to-treat rheumatoid arthritis patients who respond better to JAK inhibitors ...
A prospective PANLAR registry study found 27% of Latin American patients with chronic inflammatory arthritis started DMARDs without tuberculosis infection ...
© 2026 Scienmag - Science Magazine
© 2026 Scienmag - Science Magazine